303 related articles for article (PubMed ID: 9663420)
1. Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer.
Hiraga Y; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F; Kohno N
Oncology; 1998; 55(4):307-19. PubMed ID: 9663420
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
Oncology; 2001; 60(2):162-9. PubMed ID: 11244332
[TBL] [Abstract][Full Text] [Related]
3. Proliferating cell nuclear antigen expression correlates with the metastatic potential of submucosal invasive colorectal carcinoma.
Tanaka S; Haruma K; Tatsuta S; Hiraga Y; Teixeira CR; Shimamoto F; Yoshihara M; Sumii K; Kajiyama G
Oncology; 1995; 52(2):134-9. PubMed ID: 7854773
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of MUC1 and E-cadherin expression, cellular proliferation, and angiogenesis at the deepest invasive portion of colorectal cancer.
Kimura T; Tanaka S; Haruma K; Sumii K; Kajiyama G; Shimamoto F; Kohno N
Int J Oncol; 2000 Jan; 16(1):55-64. PubMed ID: 10601549
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma.
Furudoi A; Tanaka S; Haruma K; Kitadai Y; Yoshihara M; Chayama K; Shimamoto F
Oncology; 2002; 62(2):157-66. PubMed ID: 11914602
[TBL] [Abstract][Full Text] [Related]
6. Histologic grade and cellular proliferation at the deepest invasive portion correlate with the high malignancy of submucosal invasive gastric carcinoma.
Nishida T; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G
Oncology; 1995; 52(4):340-6. PubMed ID: 7777250
[TBL] [Abstract][Full Text] [Related]
7. MUC-1 expression as a predictor of the curative endoscopic treatment of submucosally invasive colorectal carcinoma.
Aoki R; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F; Kohno N
Dis Colon Rectum; 1998 Oct; 41(10):1262-72. PubMed ID: 9788390
[TBL] [Abstract][Full Text] [Related]
8. Proliferating cell nuclear antigen expression and its relationship to malignancy potential in invasive colorectal carcinomas.
Choi HJ; Jung IK; Kim SS; Hong SH
Dis Colon Rectum; 1997 Jan; 40(1):51-9. PubMed ID: 9102262
[TBL] [Abstract][Full Text] [Related]
9. Combined expression of urokinase-type plasminogen activator and proliferating cell nuclear antigen at the deepest invasive portion correlates with colorectal cancer prognosis.
Tatsuta S; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
Int J Oncol; 1997 Jan; 10(1):125-9. PubMed ID: 21533355
[TBL] [Abstract][Full Text] [Related]
10. Conditions of curability after endoscopic resection for colorectal carcinoma with submucosally massive invasion.
Tanaka S; Haruma K; Oh-E H; Nagata S; Hirota Y; Furudoi A; Amioka T; Kitadai Y; Yoshihara M; Shimamoto F
Oncol Rep; 2000; 7(4):783-8. PubMed ID: 10854544
[TBL] [Abstract][Full Text] [Related]
11. [Proliferating cell nuclear antigen and p53 protein expression in submucosal invasive colorectal carcinoma].
Kanazawa Y; Onda M; Tanaka N; Seya T
J Nippon Med Sch; 2000 Aug; 67(4):242-9. PubMed ID: 10938592
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of thrombospondin-1 expression in relation to vascular endothelial growth factor and interleukin-10 expression at the deepest invasive tumor site of advanced colorectal carcinoma.
Kaio E; Tanaka S; Oka S; Hiyama T; Kitadai Y; Haruma K; Chayama K
Int J Oncol; 2003 Oct; 23(4):901-11. PubMed ID: 12963968
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of angiopoietin-2 expression at the deepest invasive tumor site of advanced colorectal carcinoma.
Ochiumi T; Tanaka S; Oka S; Hiyama T; Ito M; Kitadai Y; Haruma K; Chayama K
Int J Oncol; 2004 Mar; 24(3):539-47. PubMed ID: 14767538
[TBL] [Abstract][Full Text] [Related]
14. Combined expression of HLA-DR antigen and proliferating cell nuclear antigen correlate with colorectal cancer prognosis.
Kunihiro M; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
Oncology; 1998; 55(4):326-33. PubMed ID: 9663422
[TBL] [Abstract][Full Text] [Related]
15. Proliferating cell nuclear antigen expression at the invasive tumor margin predicts malignant potential of colorectal carcinomas.
Teixeira CR; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G
Cancer; 1994 Feb; 73(3):575-9. PubMed ID: 7905362
[TBL] [Abstract][Full Text] [Related]
16. [Expression of MUC1, CD44v6, nm23 in gastric carcinomas and regional lymph node tissues and their association with invasion, metastasis, and prognosis of the tumor].
Li Y; Zhang JH; Kuang G; Yang JQ; Zhao Q; Wang XL; Jiao ZK; Zhang ZD; Wang LL
Ai Zheng; 2003 Sep; 22(9):985-9. PubMed ID: 12969535
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of subcellular localization of KL-6 mucin in primary colorectal adenocarcinoma and metastatic tissues.
Guo Q; Tang W; Inagaki Y; Midorikawa Y; Kokudo N; Sugawara Y; Nakata M; Konishi T; Nagawa H; Makuuchi M
World J Gastroenterol; 2006 Jan; 12(1):54-9. PubMed ID: 16440417
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of angiogenic factor expression at the deepest invasive site of advanced colorectal carcinoma.
Kaio E; Tanaka S; Kitadai Y; Sumii M; Yoshihara M; Haruma K; Chayama K
Oncology; 2003; 64(1):61-73. PubMed ID: 12457033
[TBL] [Abstract][Full Text] [Related]
19. Serum carcinoembryonic antigen levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma. Correlation with tumor progression and survival.
Nakamura T; Tabuchi Y; Nakae S; Ohno M; Saitoh Y
Cancer; 1996 Apr; 77(8 Suppl):1741-6. PubMed ID: 8608572
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological evaluation of biological behavior of submucosal invasive gastric carcinomas: relationship among lymph node metastasis, mucin phenotype and proliferative activity.
Nakamoto J; Torisu R; Aoki R; Kimura Y; Yasuda M; Shiota K; Yamamoto Y; Ito S
J Med Invest; 2007 Feb; 54(1-2):99-108. PubMed ID: 17380020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
